Leukodystrophy, Globoid Cell: Clinical Trials

5 trials for Leukodystrophy, Globoid Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 suspended. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Active not recruiting 1, Completed 1, Recruiting 1, Suspended 1, Terminated 1
Phase 23Active not recruiting 1, Suspended 1, Terminated 1

Follow Leukodystrophy, Globoid Cell: new trials by email Literature Review of Leukodystrophy, Globoid Cell trials Research Report on Leukodystrophy, Globoid Cell

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
FBX-101 - Krabbe Disease
Phase 1 / Phase 2Active not recruitingForge Biologics, Inc92023-02-032025-11-20
Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease
PBKR03 - Leukodystrophy, Globoid Cell
Phase 1 / Phase 2SuspendedGemma Biotherapeutics242022-02-242026-06-30
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
DUOC-01 - Adrenoleukodystrophy, Batten Disease
Phase 1RecruitingJoanne Kurtzberg, MD402014-09-012026-09-03
Human Placental-Derived Stem Cell Transplantation
Human Placental Derived Stem Cell - Mucopolysaccharidosis I, Mucopolysaccharidosis VI
Phase 1CompletedNew York Medical College432013-04-012022-10-25
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12

Narrower conditions

Adrenoleukodystrophy (3)  ·  Leukodystrophy, Metachromatic (3)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Lysosomal Storage Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Mucopolysaccharidosis I (2)  ·  Mucopolysaccharidosis II (2)  ·  Neuronal Ceroid-Lipofuscinoses (2)  ·  Niemann-Pick Diseases (2)  ·  Sandhoff Disease (2)  ·  Tay-Sachs Disease (2)  ·  alpha-Mannosidosis (2)  ·  Anemia, Aplastic (1)  ·  Anemia, Diamond-Blackfan (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Brain Diseases (4)  ·  Brain Diseases, Metabolic (4)  ·  Central Nervous System Diseases (4)  ·  Demyelinating Diseases (4)  ·  Genetic Diseases, Inborn (4)  ·  Hereditary Central Nervous System Demyelinating Diseases (4)  ·  Heredodegenerative Disorders, Nervous System (4)  ·  Leukoencephalopathies (4)  ·  Lipid Metabolism Disorders (4)  ·  Lipid Metabolism, Inborn Errors (4)  ·  Lipidoses (4)  ·  Lysosomal Storage Diseases, Nervous System (4)  ·  Metabolic Diseases (4)

Interventions

Stem Cell Transplantation (1)

Sponsors

Forge Biologics, Inc (1)  ·  Gemma Biotherapeutics (1)  ·  Joanne Kurtzberg, MD (1)  ·  New York Medical College (1)  ·  Talaris Therapeutics Inc. (1)

Countries

United States (5)  ·  Brazil (1)  ·  Canada (1)  ·  Israel (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Joanne Kurtzberg, MD (1)  ·  May Orfali, MD (1)  ·  Mitchell S Cairo, MD (1)  ·  Suzanne T Ildstad, MD (1)

Results publications

PMID 36196048, PMID 35333110, PMID 39499628